BNP PARIBAS ASSET MANAGEMENT Holding S.A. Cuts Holdings in The Clorox Company (NYSE:CLX)

BNP PARIBAS ASSET MANAGEMENT Holding S.A. reduced its position in shares of The Clorox Company (NYSE:CLX) by 7.0% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 70,050 shares of the company’s stock after selling 5,303 shares during the quarter. BNP PARIBAS ASSET MANAGEMENT Holding S.A. owned 0.06% of Clorox worth $11,412,000 as of its most recent SEC filing.

Other institutional investors have also recently modified their holdings of the company. Prospera Private Wealth LLC purchased a new position in Clorox during the third quarter worth approximately $27,000. Innealta Capital LLC acquired a new stake in Clorox in the 2nd quarter valued at $30,000. Trifecta Capital Advisors LLC increased its holdings in Clorox by 139.8% in the 2nd quarter. Trifecta Capital Advisors LLC now owns 223 shares of the company’s stock worth $30,000 after acquiring an additional 130 shares in the last quarter. Family Firm Inc. acquired a new position in Clorox during the second quarter worth $31,000. Finally, Quarry LP lifted its holdings in Clorox by 99.1% during the second quarter. Quarry LP now owns 229 shares of the company’s stock valued at $31,000 after purchasing an additional 114 shares in the last quarter. 78.53% of the stock is currently owned by institutional investors and hedge funds.

Clorox Stock Up 0.1 %

Shares of NYSE CLX opened at $169.30 on Friday. The company has a market capitalization of $20.96 billion, a P/E ratio of 58.99, a P/E/G ratio of 3.13 and a beta of 0.41. The company has a debt-to-equity ratio of 11.08, a current ratio of 1.00 and a quick ratio of 0.62. The company has a 50 day simple moving average of $162.78 and a 200-day simple moving average of $148.48. The Clorox Company has a 1 year low of $127.60 and a 1 year high of $171.35.

Clorox (NYSE:CLX) last posted its earnings results on Wednesday, October 30th. The company reported $1.86 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.36 by $0.50. Clorox had a return on equity of 316.08% and a net margin of 4.78%. The company had revenue of $1.76 billion during the quarter, compared to analysts’ expectations of $1.64 billion. During the same quarter last year, the firm earned $0.49 earnings per share. The firm’s quarterly revenue was up 27.0% compared to the same quarter last year. On average, equities research analysts predict that The Clorox Company will post 6.85 earnings per share for the current year.

Clorox Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Wednesday, January 29th will be given a $1.22 dividend. The ex-dividend date is Wednesday, January 29th. This represents a $4.88 dividend on an annualized basis and a yield of 2.88%. Clorox’s payout ratio is currently 170.04%.

Insiders Place Their Bets

In other news, EVP Angela C. Hilt sold 1,733 shares of the company’s stock in a transaction that occurred on Friday, September 6th. The shares were sold at an average price of $165.52, for a total value of $286,846.16. Following the transaction, the executive vice president now directly owns 13,471 shares in the company, valued at approximately $2,229,719.92. This represents a 11.40 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 0.57% of the stock is currently owned by insiders.

Analyst Ratings Changes

Several research firms recently weighed in on CLX. Barclays upped their price target on shares of Clorox from $137.00 to $139.00 and gave the stock an “underweight” rating in a research report on Friday, November 1st. Citigroup raised their target price on Clorox from $165.00 to $170.00 and gave the company a “neutral” rating in a research report on Friday, September 6th. JPMorgan Chase & Co. boosted their price target on Clorox from $148.00 to $174.00 and gave the stock a “neutral” rating in a research report on Friday, October 11th. TD Cowen raised Clorox from a “sell” rating to a “hold” rating and increased their price objective for the company from $155.00 to $170.00 in a research note on Wednesday, November 6th. Finally, DA Davidson lifted their target price on shares of Clorox from $153.00 to $171.00 and gave the stock a “neutral” rating in a research note on Monday, November 4th. Five analysts have rated the stock with a sell rating, ten have given a hold rating and one has given a buy rating to the stock. According to MarketBeat, the company presently has an average rating of “Hold” and a consensus price target of $155.00.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.